MiNK Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INKT and other ETFs, options, and stocks.About INKT
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
INKT Key Statistics
Stock Snapshot
With a market cap of 60.43M, MiNK Therapeutics(INKT) trades at $13.23. The stock has a price-to-earnings ratio of -4.66.
On 2025-11-08, MiNK Therapeutics(INKT) stock traded between a low of $13.13 and a high of $13.93. Shares are currently priced at $13.23, which is +0.8% above the low and -5.0% below the high.
MiNK Therapeutics(INKT) shares are trading with a volume of 25.33K, against a daily average of 21.67K.
During the past year, MiNK Therapeutics(INKT) stock moved between $4.56 at its lowest and $76.00 at its peak.
During the past year, MiNK Therapeutics(INKT) stock moved between $4.56 at its lowest and $76.00 at its peak.
INKT News
MiNK Therapeutics (INKT) announced updated clinical results evaluating agenT-797, alone and in combination with anti-PD-1 therapy, in patients with advanced sol...